'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

The trial evaluates THIO's safety, tolerability, and efficacy in combination with PD-(L)1 inhibition. THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo ® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology.

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

PI Industries Ltd., incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 51,881.53 Crore) operating in Pesticides/Agro Chemicals sector. PI Industries Ltd. key ...

This is a port of Arduino to the RP2040 (Raspberry Pi Pico processor) and RP2350 (Raspberry Pi Pico 2 processor). It uses the bare Raspberry Pi Pico SDK and a custom GCC 14.2/Newlib 4.3 toolchain and ...

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair. A new artificial intelligence (AI) model designed to ...